Evaluating Lip Repositioning for the Treatment of Excess Gingival Display With and Without Pretreatment With Botox
Gingival Overgrowth
About this trial
This is an interventional treatment trial for Gingival Overgrowth
Eligibility Criteria
Inclusion Criteria:
- Gummy smile more than 3mm.
- Adults >18 years.
- Non-smokers.
- Patients with healthy systemic condition
- Normal clinical crown dimensions.
- Good oral hygiene.
Exclusion Criteria:
- Natural dentition upper anterior
- Pregnant or lactating women.
- Patients with inflamed gingiva or gingival enlargement.
- Inflammation or infection at the site of injection.
- Patients with allergy to botulinum toxin, lactose, and albumin.
- Concurrent use of aminoglycoside antibiotic that enhances the action of the toxin. (Jaspers, Pijpe, & Jansma, 2011)
- < 3 mm attached gingivae that might create difficulties in flap design, stabilization and suturing.
- Patients using anticholinesterase or other agents interfering with neuromuscular transmission
Sites / Locations
Arms of the Study
Arm 1
Arm 2
Experimental
Active Comparator
lip repositioning technique with Botox injection.
lip repositioning technique.
Botulinum toxin produces partial chemical denervation of the muscle resulting in localized reduction in muscle activity (Binder et al., 1998). Therefore, the technique is a useful adjunct in the esthetic improvement of the smile and provides better results when combined with resective gingival surgery(Pedron & Mangano, 2018).
Lip repositioning aims to limit the retraction of elevator smile muscles. Lip repositioning results in a shallow vestibuler restricting of the muscle pull; Thereby limiting the gingival display during smiling.(Makkiah, 2017) It is a less invasive, viable substitute for patients, has fewer post-operative complications and provides a faster recovery compared to orthognathic surgery(Grover, Gupta, & Luthra, 2014).